Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
“Families and health care professionals now have the option to consider a once-weekly growth hormone as treatment with 313 injection free days per year for their children 2.5 years and older with ISS, NS, and born SGA,” said Dr Aristides Maniatis, Founder, Rocky Mountain Pediatric Endocrinology.
Endocrinology, Diabetes, Metabolism April 9th 2026
Journal of Advanced Nursing (JAN)
The societal influences, including parental weight stigma, affect how parents perceive their child’s weight and respond to health care recommendations.
Pediatric Nursing February 13th 2026
Pharmacy Times
“We try to deescalate pharmacotherapy as soon as we can in children. How’s this going to affect puberty? How’s it going to affect growth? We don’t have those long-term data.”
Clinical Pharmacology December 11th 2025
Analysis of more than 5 million adolescent insurance claims reveals that gender-affirming medication prescriptions remain exceptionally rare, with peak rates reaching only 140.16 per 100,000 at age 17 for AFAB adolescents.
Pediatrics February 12th 2025
Journal of the Endocrine Society (JES)
Initial visit laboratory values, particularly HbA1C and 2-hour glucose, combined with BMI trajectory, offer more reliable predictive value for T2D progression than traditional fasting plasma glucose measurements.
Endocrinology, Diabetes, Metabolism January 30th 2025
The Journal of Clinical Endocrinology & Metabolism (JCEM)
Current evidence indicates positive mental health outcomes with gender-affirming care, with studies showing decreased rates of depression, self-harm, and suicidal ideation among treated adolescents.
Family Medicine/General Practice October 29th 2024